The Latest

BigHat’s CSO on Biocom CA’s Lifelines Podcast

BigHat Appoints John Corbin, PhD as Chief Development Officer

BigHat Year in Review 2022

BigHat Biosciences Announces Research Collaboration with Merck

BigHat Biosciences validates best-in-class security posture with spotless SOC2 audit

BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies

BigHat’s CSO and VP Engineering speaking at AWS Summit San Francisco

BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors

BigHat Biosciences Completes Its Acquisition of Frugi Biotechnology

Luminaries Rob Chess, Mark Pegram and Michael Jewett join BigHat’s Advisory Board

BigHat in Pharma’s Almanac Q1 2022 Issue

BigHat’s CEO and CSO on BIOS Builders podcast